Get the Stockscreener App
4.87
10.18%
0.45
After Hours:
4.96
0.09
+1.85%
Seastar Medical Holding Corp stock is traded at $4.87, with a volume of 165.16K.
It is up +10.18% in the last 24 hours and up +6.33% over the past month.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
See More
Previous Close:
$4.42
Open:
$4.4
24h Volume:
165.16K
Relative Volume:
1.21
Market Cap:
$19.47M
Revenue:
$1.23M
Net Income/Loss:
$-12.15M
P/E Ratio:
-1.1268
EPS:
-4.3221
Net Cash Flow:
$-13.60M
1W Performance:
+25.84%
1M Performance:
+6.33%
6M Performance:
+5.62%
1Y Performance:
-61.95%
1-Day Range:
$4.38
$5.055
1-Week Range:
$3.80
$5.055
52-Week Range:
$2.07
$13.40
Seastar Medical Holding Corp Stock (ICU) Company Profile
Name
Seastar Medical Holding Corp
Sector
Industry
Phone
844-427-8100
Address
3513 BRIGHTON BLVD, DENVER
Compare ICU vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
4.87 | 17.67M | 1.23M | -12.15M | -13.60M | -4.3221 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Seastar Medical Holding Corp Stock (ICU) Latest News
SeaStar Medical Holding Corporation to Announce First Quarter Financial Results on May 13, 2026 - Quiver Quantitative
SeaStar Medical sets May 13 webcast for Q1 results and update - Stock Titan
[EFFECT] SeaStar Medical Holding Corp SEC Filing - Stock Titan
SeaStar Medical (NASDAQ: ICU) seeks approval to expand 2022 equity incentive plan - Stock Titan
SeaStar Medical (NASDAQ: ICU) registers 65,068 resale shares; warrants could bring $74M - Stock Titan
SeaStar Medical (NASDAQ: ICU) updates S-1; registers 493,542 shares and related warrants - Stock Titan
SeaStar Medical (NASDAQ: ICU) files S-1 for Lincoln Park resale facility - Stock Titan
Securities class action against SeaStar Medical (NASDAQ: ICU) dismissed with prejudice - Stock Titan
ICU DEADLINE TOMORROW: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important September 6 Deadline in Securities Class ActionICU - TMX Newsfile
ICUCW (SeaStar) quarterly earnings results have not been disclosed, with no performance or stock reaction data available.Verified Analyst Reports - Newser
ICU Financials: Income Statement, Balance Sheet & Cash Flow | SeaStar Medical Holding Corp - Stock Titan
SeaStar (ICU) Stock: Why Network Effect (Dips) 2026-04-20Trending Social Stocks - Newser
SeaStar (ICU) Stock Discretionary Trade (+2.93%) 2026-04-15Crowd Entry Points - Newser
Is SeaStar (ICU) Stock at a Peak | Price at $4.10, Up 10.51%Quote Data - Newser
RSI Check: Can SeaStar Medical Holding Corporation Equity Warrant reach all time highs this year - baoquankhu1.vn
Trade Report: What are the future prospects of SeaStar Medical Holding CorporationInsider Selling & Real-Time Volume Spike Alerts - baoquankhu1.vn
US Market Recap: Is SeaStar Medical Holding Corporation Equity Warrant still a buy after recent gains2026 Top Gainers & Precise Entry and Exit Recommendations - baoquankhu1.vn
SeaStar Medical (NASDAQ:ICU) & Selectis Health (OTCMKTS:GBCS) Critical Comparison - Defense World
Market Catalysts: Whats the MACD signal for SeaStar Medical Holding Corporation2026 Price Targets & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Pullback Watch: Can SeaStar Medical Holding Corporation continue delivering strong returns2026 Setups & Safe Entry Trade Signal Reports - baoquankhu1.vn
ICU PE Ratio & Valuation, Is ICU Overvalued - Intellectia AI
SeaStar Medical presents pediatric AKI data at conference - Investing.com
Risks Report: Can SeaStar Medical Holding Corporation Equity Warrant continue delivering strong returnsPortfolio Update Summary & Fast Gaining Stock Reports - baoquankhu1.vn
Trend Recap: Can SeaStar Medical Holding Corporation Equity Warrant reach all time highs this year2026 Top Gainers & Precise Entry and Exit Recommendations - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
SeaStar Medical presents pediatric AKI data at conference By Investing.com - ca.investing.com
SeaStar Medical Reports Positive SAVE Registry Data on Pediatric AKI Treatment and Hosts Expert Symposium - Quiver Quantitative
New pediatric AKI data show 69% survival with no device issues - Stock Titan
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026 - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
SeaStar Medical Holding Corp (ICU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Gains Report: Can SeaStar Medical Holding Corporation Equity Warrant reach all time highs this year2026 Trade Ideas & AI Based Buy and Sell Signals - baoquankhu1.vn
SeaStar Medical Holding Corp reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings call transcript: SeaStar Medical’s Q4 2025 revenue soars, stock edges up - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
SeaStar Medical Holding 2025 10-K: Revenue $1.234M, EPS $(5.86) - TradingView
SeaStar Medical (NASDAQ: ICU) details QUELIMMUNE launch and pivotal AKI trial - Stock Titan
SEASTAR MEDICAL HOLDING ($ICU) Releases Q4 2025 Earnings - Quiver Quantitative
SeaStar Medical reports $1.2M revenue for 2025, narrows annual loss to $12.2M - TradingView
[8-K] SeaStar Medical Holding Corp Reports Material Event - Stock Titan
SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - ChartMill
SeaStar Medical Holding Corp expected to post a loss of $1.06 a shareEarnings Preview - TradingView
If You Invested $1,000 in SeaStar Medical Holding Corp (ICU) - Stock Titan
ICU Technical Analysis & Stock Price Forecast - Intellectia AI
Aug Catalysts: Can SeaStar Medical Holding Corporation continue delivering strong returnsSell Signal & Reliable Intraday Trade Alerts - baoquankhu1.vn
EV Market: Can SeaStar Medical Holding Corporation be the next market leaderQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
SeaStar Medical Highlights SCD Platform, QUELIMMUNE Growth and NEUTRALIZE-AKI Timeline at Forum - Defense World
Insider Buy: Will SeaStar Medical Holding Corporation stock recover after earnings2026 Top Decliners & Accurate Technical Buy Alerts - baoquankhu1.vn
SeaStar Medical (ICU) Expected to Announce Earnings on Thursday - Defense World
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026 - ChartMill
OTC Markets Hosts Virtual Investor Presentation with Eric Schlorff, CEO of SeaStar Medical, and David Bautz, PhD, Senior Analyst at Zacks SCR - Yahoo Finance
Seastar Medical Holding Corp Stock (ICU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seastar Medical Holding Corp Stock (ICU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Messinger Michael | Chief Financial Officer |
Dec 09 '25 |
Buy |
0.35 |
14,500 |
5,098 |
17,500 |
| Van Heel Kenneth | Director |
Aug 26 '25 |
Buy |
0.89 |
25,000 |
22,248 |
39,400 |
| Van Heel Kenneth | Director |
Aug 27 '25 |
Buy |
0.86 |
10,000 |
8,565 |
49,400 |
| Chung Kevin | Chief Medical Officer |
Aug 22 '25 |
Buy |
0.80 |
10,000 |
8,000 |
58,184 |
| Neuman John | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
88,000 |
| Vincent Bernadette N | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
8,000 |
| Van Heel Kenneth | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
4,000 |
0 |
10,400 |
| Chung Kevin | Chief Medical Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
5,000 |
0 |
48,184 |
| Schlorff Eric | Chief Executive Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
21,667 |
0 |
98,517 |
| Baird Jennifer A | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
18,000 |
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):